Personal opinion Andrew but i honestly think it deserves double digits under the current deals simply based on the level of interest shown by the upper house....
double digits equal a fully diluted $30m market cap
not neccesarily saying it is required to act the same as other parties & not implying that all outcomes will be succesfull but i'll put up the question anyway -
Find any other biotech in partnership with 3 of the worlds top 10 pharmaceutical companies that is valued at under $100m....
PS - i don't think you'll find any in Aust.
Patience is king... :-)
chart - break up?, page-36
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.3¢ | 10.3¢ | 10.0¢ | $13.42K | 134.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 1207416 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 1299539 | 10 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |